FDA shuts 3 Cadila warehouses over Aciloc labelling confusion

Maharashtra's Food and Drug Administration has shut down three warehouses operated by Cadila Healthcare following a labelling mix-up involving the acidity medication Aciloc.

The action was taken after officials identified confusion in the packaging and naming of the product across the storage facilities. The FDA directed the company to address the compliance issues before operations resume.

Cadila Healthcare has been directed to rectify the labelling discrepancies and submit compliance documentation to the regulatory authority.